Luxottica reported flat sales at CER and squeezed margins in H1. The outlook was unchanged for 2018. The merger with Essilor is waiting for approval from the Chinese authorities.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Luxottica reported flat sales at CER and squeezed margins in H1. The outlook was unchanged for 2018. The merger with Essilor is waiting for approval from the Chinese authorities.
